Bragar Eagel & Squire Investigates Certara on Behalf of Stockholders

Regulation
โดย GlobeNewswire·Read original
Summary · why it matters

Bragar Eagel & Squire, P.C. is investigating potential claims against Certara, Inc. on behalf of Certara stockholders. The investigation concerns whether Certara violated federal securities laws or engaged in other unlawful business practices. The inquiry follows Certara's May 11, 2026 announcement of first-quarter 2026 financial results, which included a 4% year-over-year decline in services revenue to $57.2 million and a 14% drop in services bookings to $66.6 million. The company also disclosed its exit from the regulatory business within its services segment and described services performance as mixed. Certara shares fell $1.18, or approximately 19%, from $6.31 on May 8, 2026 to close at $5.13 on May 11, 2026.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Certara Inc
CERT
▼ NegativeCapitalrelevance

Certara reported a 4% decline in services revenue and a 14% drop in services bookings, and exited its regulatory business, causing a 19% stock drop.